Document is current
Any future updates will be listed below
-
Authors
Kim, Hyun-Jin https://orcid.org/0000-0002-7885-1695
Kim, Hyue Mee https://orcid.org/0000-0001-7680-6690
Kim, Dae-Hee https://orcid.org/0000-0002-8275-4871
-
Clinical Trials BETA
Clinical trials referenced in this document:
kct0010343 at Clinical Research Information Service, Republic of KoreaDocuments that mention this clinical trial
Single-Pill Combination Olmesartan/Amlodipine/Hydrochlorothiazide Safety and Effectiveness in Older Patients with Hypertension: Pooled Analysis of Post-Approval Observational Studies
https://doi.org/10.1007/s12325-026-03573-9
-
Funding
Funding for this research was provided by:
Daiichi Sankyo Korea Co., Ltd.
- License Information
-
More Information
Article History
Received: 3 September 2025
Accepted: 13 March 2026
First Online: 31 March 2026
Declarations
:
: Hyun-Jin Kim and Hyue Mee Kim declare that they have no competing interests. Dae-Hee Kim has received honoraria from Viatris, Organon, Boryoung, Hanmi, Daewoong, Celltrion, Daiichi Sankyo, and Chong Kun Dang, and a research grant from Daewoong.
: The study protocol was approved by the Institutional Review Board of Asan Medical Center, Seoul, Republic of Korea (IRB no. 2024–0503) and was conducted in accordance with the principles of the Declaration of Helsinki 1964 and its later amendments, as well as the rules of the IRB. All patients voluntarily provided written informed consent before enrolling in the study. Study data were de-identified to protect the privacy of the participating patients and to comply with locally applicable regulations.
